Please login to the form below

Not currently logged in
Email:
Password:

health technology assessment

This page shows the latest health technology assessment news and features for those working in and with pharma, biotech and healthcare.

NICE’s long-serving chief exec Sir Andrew Dillon to step down

NICE’s long-serving chief exec Sir Andrew Dillon to step down

NICE quickly became the world’s  best-known and most prominent health technology assessment (HTA) body, and has set the standard for many other national institutes set up since then. ... NICE has made a significant contribution to improving outcomes

Latest news

More from news
Approximately 1 fully matching, plus 153 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 44 partially matching documents found.

Latest appointments

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... I am delighted to join the ABPI at this time of great

  • Former NICE chair joins board of biotech Former NICE chair joins board of biotech

    I no longer have anything to do with [NICE],” he told the FT, clarifying his future influence on the health technology assessment (HTA) body. ... His expertise in the cost-effectiveness of new pharmaceuticals and other issues in health economics will

  • Access Partnership expands its senior team Access Partnership expands its senior team

    His international experience extends to product development and commercialisation, health economics, health outcomes research, health technology assessment, market access and pricing strategies.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics